At a glance
This program funds short-term exploratory clinical trials for arthritis, musculoskeletal, and skin conditions or diseases, including early-stage studies such as first-in-human, dose-finding, safety, and biomarker studies. Applicants may be higher education institutions, nonprofits, governments, tribes, faith-based or community-based organizations, regional organizations, foreign organizations, and other eligible entities, but non-domestic non-U.S. entities and non-domestic components of U.S. organizations are not eligible; foreign components are allowed. The combined direct-cost budget for three years may not exceed $600,000, with no more than $300,000 in direct costs in any single year, and the project period may be up to three years. No cost sharing is required.
What it funds
Official description from grants.gov
This Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required) PAR, a re-issue of PAR-24-035, was re-issued as a result of the Simplifying Review of Research Project Grant Applications [link: https://grants.nih.gov/policy-and-compliance/policy-topics/peer-review/simplifying-review]. The Simplify Review changes in Section V are the only changes that have been made. All other aspects of this funding opportunity remain the same.
Who can apply
- City or township governments
- County governments
- For-profit organizations other than small businesses
- Independent school districts
- Native American tribal governments (Federally recognized)
- Native American tribal organizations (other than Federally recognized)
- Nonprofits with 501(c)(3) status (other than higher education)
- Nonprofits without 501(c)(3) status (other than higher education)
- Others
- Private institutions of higher education
- Public and State controlled institutions of higher education
- Public housing authorities / Indian housing authorities
- Small businesses
- Special district governments
- State governments